Eric Boersma

Author PubWeight™ 431.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011 13.10
2 Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007 7.61
3 A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003 6.88
4 Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009 6.82
5 Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007 6.51
6 Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009 5.26
7 Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007 5.02
8 Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003 4.06
9 Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004 3.87
10 Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006 3.50
11 Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial. JAMA Intern Med 2013 3.46
12 A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 2007 3.28
13 Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. Eur Heart J 2012 3.19
14 Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol 2006 3.16
15 Concern Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009 3.14
16 A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007 2.91
17 Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation 2007 2.85
18 Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005 2.83
19 Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J Am Coll Cardiol 2008 2.81
20 Diagnostic accuracy and clinical utility of noninvasive testing for coronary artery disease. Ann Intern Med 2010 2.80
21 Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008 2.75
22 Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 2005 2.74
23 Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 2006 2.74
24 Gender differences in the management and clinical outcome of stable angina. Circulation 2006 2.59
25 Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough. Circulation 2010 2.56
26 Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 2006 2.54
27 Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol 2010 2.51
28 Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J 2006 2.48
29 Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation 2010 2.30
30 The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J Am Coll Cardiol 2012 2.27
31 2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management. Heart 2013 2.18
32 Feasibility of diastolic function assessment with cardiac CT: feasibility study in comparison with tissue Doppler imaging. JACC Cardiovasc Imaging 2011 2.18
33 N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol 2013 2.15
34 Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J 2008 2.13
35 Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 2003 2.08
36 A comparison of the lateral and posterior approach for brachial plexus block. Reg Anesth Pain Med 2006 2.07
37 Characterizing vulnerable plaque features with intravascular elastography. Circulation 2003 2.07
38 Postoperative mortality in The Netherlands: a population-based analysis of surgery-specific risk in adults. Anesthesiology 2010 2.04
39 64-slice computed tomography coronary angiography in patients with high, intermediate, or low pretest probability of significant coronary artery disease. J Am Coll Cardiol 2007 2.04
40 Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry. Int J Cardiol 2012 2.04
41 Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 2004 2.02
42 Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 2005 1.99
43 Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 2009 1.99
44 Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2004 1.99
45 Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2010 1.92
46 Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003 1.90
47 Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008 1.87
48 Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system--a Bern-Rotterdam Study. Am Heart J 2010 1.87
49 Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 2008 1.84
50 Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006 1.84
51 Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 2006 1.83
52 Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 2004 1.82
53 Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. Lancet 2012 1.80
54 Automated quantification of coronary plaque with computed tomography: comparison with intravascular ultrasound using a dedicated registration algorithm for fusion-based quantification. Eur Heart J 2012 1.80
55 Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography in the non-invasive evaluation of significant coronary artery disease. Eur Heart J 2010 1.77
56 Phase analysis of gated myocardial perfusion single-photon emission computed tomography compared with tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J Am Coll Cardiol 2007 1.73
57 Factors affecting sensitivity and specificity of diagnostic testing: dobutamine stress echocardiography. J Am Soc Echocardiogr 2009 1.67
58 Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003 1.67
59 Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. Eur Heart J 2004 1.66
60 The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005 1.65
61 The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina. Eur Heart J 2005 1.64
62 Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009 1.63
63 Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome. Heart 2011 1.62
64 Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study. BMJ 2006 1.61
65 The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. Eur Heart J 2009 1.60
66 Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 2009 1.59
67 Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes. Eur Heart J 2006 1.59
68 Smoking behaviour in European patients with established coronary heart disease. Eur Heart J 2005 1.58
69 Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010 1.57
70 Guidelines for cardiac management in noncardiac surgery are poorly implemented in clinical practice: results from a peripheral vascular survey in the Netherlands. Anesthesiology 2007 1.57
71 Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy. Am Heart J 2010 1.56
72 Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010 1.56
73 Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg 2008 1.52
74 Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 2006 1.51
75 Influence of noninvasive cardiovascular imaging in primary prevention: systematic review and meta-analysis of randomized trials. Arch Intern Med 2011 1.50
76 Usefulness of myocardial tissue Doppler echocardiography to evaluate left ventricular dyssynchrony before and after biventricular pacing in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2003 1.50
77 Prehospital versus hospital fibrinolytic therapy using automated versus cardiologist electrocardiographic diagnosis of myocardial infarction: abortion of myocardial infarction and unjustified fibrinolytic therapy. Am Heart J 2004 1.48
78 Assessment of residual myocardial viability in regions with chronic electrocardiographic Q-wave infarction. Am Heart J 2002 1.48
79 Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? Am Heart J 2006 1.48
80 Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging. JACC Cardiovasc Interv 2010 1.47
81 Determinants of high cardiovascular risk in relation to plaque-composition of a non-culprit coronary segment visualized by near-infrared spectroscopy in patients undergoing percutaneous coronary intervention. Eur Heart J 2013 1.47
82 Adjunctive value of CT coronary angiography in the diagnostic work-up of patients with typical angina pectoris. Eur Heart J 2007 1.46
83 The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials. J Am Coll Cardiol 2012 1.46
84 Short- and long-term major adverse cardiac events in patients undergoing percutaneous coronary intervention with stenting for acute myocardial infarction complicated by cardiogenic shock. Cardiology 2012 1.46
85 Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years. Catheter Cardiovasc Interv 2012 1.45
86 Perioperative and long-term cardiovascular outcomes in patients undergoing endovascular treatment compared with open vascular surgery for abdominal aortic aneurysm or iliaco-femoro-popliteal bypass. Am J Cardiol 2005 1.44
87 Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 2007 1.44
88 Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization. J Nucl Med 2002 1.42
89 NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography. JACC Cardiovasc Imaging 2011 1.42
90 Non-invasive diagnostic workup of patients with suspected stable angina by combined computed tomography coronary angiography and magnetic resonance perfusion imaging. Circ J 2011 1.42
91 Spinal anesthesia for intrapartum Cesarean delivery following epidural labor analgesia: a retrospective cohort study. Can J Anaesth 2009 1.41
92 Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit. Pharmacogenomics 2010 1.41
93 Standardized screening and treatment of patients with life-threatening arrhythmias: the Leiden out-of-hospital cardiac arrest evaluation study. Heart Rhythm 2004 1.41
94 Normal biventricular function, volumes, and mass in children aged 8 to 17 years. J Magn Reson Imaging 2009 1.40
95 Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries. J Invasive Cardiol 2011 1.39
96 A new intracoronary measurement catheter, MetriCath, compared to intravascular ultrasound and quantitative coronary angiography in a stented porcine coronary model. Catheter Cardiovasc Interv 2002 1.39
97 Two-dimensional quantitative coronary angiographic models for bifurcation segmental analysis: in vitro validation of CAAS against precision manufactured plexiglas phantoms. Catheter Cardiovasc Interv 2011 1.39
98 Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J 2005 1.39
99 Predicting the unpredictable: a new prediction model for operating room times using individual characteristics and the surgeon's estimate. Anesthesiology 2010 1.35
100 Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007 1.32
101 Incremental prognostic value of multi-slice computed tomography coronary angiography over coronary artery calcium scoring in patients with suspected coronary artery disease. Eur Heart J 2009 1.32
102 Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 2009 1.32
103 The long-term prognostic value of the resting and postexercise ankle-brachial index. Arch Intern Med 2006 1.31
104 Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation 2002 1.30
105 Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol 2007 1.30
106 Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med 2004 1.29
107 The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur Heart J 2005 1.28
108 Use of 64-slice CT in symptomatic patients after coronary bypass surgery: evaluation of grafts and coronary arteries. Eur Heart J 2006 1.27
109 Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS One 2013 1.27
110 Effectiveness of resynchronization therapy in patients with end-stage heart failure. Am J Cardiol 2002 1.24
111 Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 2004 1.24
112 Relative merits of M-mode echocardiography and tissue Doppler imaging for prediction of response to cardiac resynchronization therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2006 1.20
113 Effect of pulmonary vein anatomy and left atrial dimensions on outcome of circumferential radiofrequency catheter ablation for atrial fibrillation. Am J Cardiol 2011 1.19
114 Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization. Eur Heart J 2006 1.18
115 Speckle-tracking radial strain reveals left ventricular dyssynchrony in patients with permanent right ventricular pacing. J Am Coll Cardiol 2007 1.18
116 Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J 2008 1.17
117 Optimizing the prediction of perioperative mortality in vascular surgery by using a customized probability model. Arch Intern Med 2005 1.17
118 Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. Circulation 2003 1.17
119 Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers. J Am Coll Cardiol 2006 1.16
120 Incidence, pathophysiology, and treatment of complications during dobutamine-atropine stress echocardiography. Circulation 2010 1.16
121 Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur J Cardiothorac Surg 2005 1.16
122 In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J 2013 1.16
123 Left ventricular dyssynchrony acutely after myocardial infarction predicts left ventricular remodeling. J Am Coll Cardiol 2007 1.15
124 Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One 2010 1.15
125 Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol 2006 1.15
126 n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. Diabetes Care 2011 1.14
127 Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am J Cardiol 2010 1.12
128 Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation 2003 1.12
129 Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ Cardiovasc Interv 2014 1.12
130 Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 2004 1.11
131 Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol 2006 1.11
132 Right ventricular quantification in clinical practice: two-dimensional vs. three-dimensional echocardiography compared with cardiac magnetic resonance imaging. Eur J Echocardiogr 2011 1.10
133 Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Am J Cardiol 2008 1.08
134 Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol 2004 1.08
135 Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II? Am J Cardiol 2005 1.07
136 Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability. Circulation 2004 1.05
137 Prognostic value of right ventricular function in patients after acute myocardial infarction treated with primary percutaneous coronary intervention. Circ Cardiovasc Imaging 2010 1.05
138 Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients. J Nucl Med 2006 1.05
139 Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. Eur Heart J 2006 1.05
140 Impact of heart rate frequency and variability on radiation exposure, image quality, and diagnostic performance in dual-source spiral CT coronary angiography. Radiology 2009 1.05
141 One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 2005 1.04
142 A prognostic risk index for long-term mortality in patients with peripheral arterial disease. Arch Intern Med 2007 1.04
143 Prognostic importance of strain and strain rate after acute myocardial infarction. Eur Heart J 2010 1.03
144 Prognostic value of coronary vessel dominance in relation to significant coronary artery disease determined with non-invasive computed tomography coronary angiography. Eur Heart J 2012 1.03
145 The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg 2007 1.01
146 Comprehensive assessment of spotty calcifications on computed tomography angiography: comparison to plaque characteristics on intravascular ultrasound with radiofrequency backscatter analysis. J Nucl Cardiol 2011 1.01
147 Atrial fibrillation: multi-detector row CT of pulmonary vein anatomy prior to radiofrequency catheter ablation--initial experience. Radiology 2005 0.99
148 Quantitative gated SPECT-derived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapy. J Nucl Med 2009 0.99
149 Recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 2005 0.99
150 Noninvasive assessment of plaque characteristics with multislice computed tomography coronary angiography in symptomatic diabetic patients. Diabetes Care 2007 0.98
151 Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J Thorac Cardiovasc Surg 2004 0.98
152 Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J 2011 0.98
153 Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram? Am J Cardiol 2005 0.97
154 Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study. Am Heart J 2011 0.97
155 Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 2005 0.96
156 Usefulness of dynamic multislice computed tomography of left ventricular function in unstable angina pectoris and comparison with echocardiography. Am J Cardiol 2002 0.96
157 The electrical T-axis and the spatial QRS-T angle are independent predictors of long-term mortality in patients admitted with acute ischemic chest pain. Cardiology 2004 0.96
158 Applicability of clinical prediction models in acute myocardial infarction: a comparison of traditional and empirical Bayes adjustment methods. Am Heart J 2005 0.96
159 Biomarkers of heart failure with normal ejection fraction: a systematic review. Eur J Heart Fail 2013 0.96
160 Early versus delayed revascularization in patients with ischemic cardiomyopathy and substantial viability: impact on outcome. Circulation 2003 0.95
161 [ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome) 2012 0.95
162 The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina. Eur Heart J 2006 0.95
163 Vertical infraclavicular block of the brachial plexus: effects on hemidiaphragmatic movement and ventilatory function. Reg Anesth Pain Med 2005 0.95
164 Prognostic value of routine preoperative electrocardiography in patients undergoing noncardiac surgery. Am J Cardiol 2006 0.94
165 Comparison of left atrial volumes and function by real-time three-dimensional echocardiography in patients having catheter ablation for atrial fibrillation with persistence of sinus rhythm versus recurrent atrial fibrillation three months later. Am J Cardiol 2008 0.94
166 Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. Eur Heart J 2010 0.94
167 The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries. JACC Cardiovasc Interv 2010 0.93
168 Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue. Eur Heart J 2009 0.93
169 Cardiac multidetector-row computed tomography in patients with unstable angina. Am J Cardiol 2005 0.93
170 Viability assessment with global left ventricular longitudinal strain predicts recovery of left ventricular function after acute myocardial infarction. Circ Cardiovasc Imaging 2009 0.93
171 Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants. Eur Heart J 2011 0.92
172 Diagnostic performance of non-invasive multidetector computed tomography coronary angiography to detect coronary artery disease using different endpoints: detection of significant stenosis vs. detection of atherosclerosis. Eur Heart J 2010 0.92
173 The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation. Heart 2006 0.91
174 Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic function. Circ Cardiovasc Imaging 2011 0.91
175 Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. J Am Coll Cardiol 2010 0.91
176 Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes. Eur Heart J 2006 0.91
177 Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. Am Heart J 2004 0.90
178 The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol 2012 0.90
179 Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol 2011 0.90
180 High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration. Am Heart J 2011 0.90
181 Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am J Cardiol 2006 0.90
182 Smoking and its effects on mortality in adults with congenital heart disease. Int J Cardiol 2007 0.90
183 Adherence to guidelines in the clinical care for adults with congenital heart disease: the Euro Heart Survey on adult congenital heart disease. Eur Heart J 2006 0.89
184 Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry. Eur J Prev Cardiol 2012 0.89
185 Automated quantification of stenosis severity on 64-slice CT: a comparison with quantitative coronary angiography. JACC Cardiovasc Imaging 2010 0.89
186 High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 2006 0.89
187 Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial. Arch Intern Med 2007 0.89
188 C-reactive protein and B-type natriuretic peptide yield either a non-significant or a modest incremental value to traditional risk factors in predicting long-term overall mortality in older adults. PLoS One 2013 0.88
189 Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups. Heart 2006 0.88
190 Intra-individual changes in anxiety and depression during 12-month follow-up in percutaneous coronary intervention patients. J Affect Disord 2011 0.88
191 Assessment with multi-slice computed tomography and gray-scale and virtual histology intravascular ultrasound of gender-specific differences in extent and composition of coronary atherosclerotic plaques in relation to age. Am J Cardiol 2010 0.88
192 The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review. Expert Rev Cardiovasc Ther 2013 0.87
193 Overweight and class I obesity are associated with lower 10-year risk of mortality in Brazilian older adults: the Bambuí Cohort Study of Ageing. PLoS One 2012 0.87
194 Perfusion and contractile reserve in chronic dysfunctional myocardium: relation to functional outcome after surgical revascularization. Circulation 2002 0.87
195 Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy. Eur Heart J 2008 0.87
196 Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis. J Epidemiol Community Health 2005 0.87
197 Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS. Am Heart J 2004 0.87
198 Inadequate control of heart rate in patients with stable angina: results from the European heart survey. Postgrad Med J 2010 0.87
199 Gelatinolytic activity in atherosclerotic plaques is highly localized and is associated with both macrophages and smooth muscle cells in vivo. Circulation 2007 0.87
200 Results of staged total cavopulmonary connection for functionally univentricular hearts; comparison of intra-atrial lateral tunnel and extracardiac conduit. Eur J Cardiothorac Surg 2009 0.87
201 Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities. EuroIntervention 2016 0.87
202 Predictive value of total atrial conduction time estimated with tissue Doppler imaging for the development of new-onset atrial fibrillation after acute myocardial infarction. Am J Cardiol 2010 0.86
203 Effects of statins on renal function after aortic cross clamping during major vascular surgery. Am J Cardiol 2006 0.86
204 Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods. Circulation 2004 0.86
205 Impact of percutaneous coronary intervention or coronary artery bypass grafting on outcome after nonfatal cardiac arrest outside the hospital. Am J Cardiol 2003 0.86
206 Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's age. JACC Cardiovasc Interv 2010 0.86
207 Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT). Eur Heart J 2009 0.86
208 EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. Eur Heart J 2011 0.85
209 Wall motion score index predicts mortality and functional result after surgical ventricular restoration for advanced ischemic heart failure. Eur J Cardiothorac Surg 2009 0.85
210 Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol 2005 0.85
211 Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort. Int J Cardiol 2007 0.85
212 In vivo temperature heterogeneity is associated with plaque regions of increased MMP-9 activity. Eur Heart J 2005 0.85
213 Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study). Am J Cardiol 2009 0.85
214 Lipoprotein(a), interleukin-10, C-reactive protein, and 8-year outcome after percutaneous coronary intervention. Clin Cardiol 2012 0.85
215 Comparison of the roll plate method to the sonication method to diagnose catheter colonization and bacteremia in patients with long-term tunnelled catheters: a randomized prospective study. J Clin Microbiol 2009 0.85
216 Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Am Heart J 2004 0.85
217 The usefulness of brain natriuretic peptide in simple congenital heart disease - a systematic review. Cardiol Young 2012 0.84
218 Prognostic value of renal dysfunction for the prediction of outcome versus results of computed tomographic coronary angiography. Am J Cardiol 2011 0.84
219 Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Lancet 2002 0.84
220 Cardiac support device, restrictive mitral valve annuloplasty, and optimized medical treatment: a multimodality approach to nonischemic cardiomyopathy. J Thorac Cardiovasc Surg 2011 0.84
221 Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease. Am J Cardiol 2013 0.84
222 Does a gender difference in response to cardiac resynchronization therapy exist? Pacing Clin Electrophysiol 2005 0.84
223 Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery. Heart 2006 0.84
224 Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography. Arterioscler Thromb Vasc Biol 2014 0.84
225 Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting. EuroIntervention 2012 0.84
226 The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3). EuroIntervention 2012 0.84
227 The "obesity paradox" in an elderly population with a high prevalence of Chagas disease: the 10-year follow-up of the Bambuí (Brazil) Cohort Study of Aging. Int J Cardiol 2012 0.84
228 The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial. J Am Coll Cardiol 2007 0.83
229 The effect of internal thoracic artery grafts on long-term clinical outcomes after coronary bypass surgery. J Thorac Cardiovasc Surg 2011 0.83
230 Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablation. Am Heart J 2011 0.83
231 Predictive value of multislice computed tomography variables of atherosclerosis for ischemia on stress-rest single-photon emission computed tomography. Circ Cardiovasc Imaging 2010 0.83
232 Comparison of Candesartan versus Metoprolol for treatment of systemic hypertension after repaired aortic coarctation. Am J Cardiol 2009 0.83
233 Comparison of effectiveness of cardiac resynchronization therapy in patients <70 versus > or =70 years of age. Am J Cardiol 2005 0.83
234 Usefulness of real-time three-dimensional echocardiography to identify right ventricular dysfunction in patients with congenital heart disease. Am J Cardiol 2010 0.83
235 Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy. Am J Cardiol 2010 0.83
236 Scar tissue on contrast-enhanced MRI predicts left ventricular remodelling after acute infarction. Heart 2007 0.82
237 Does left ventricular dyssynchrony immediately after acute myocardial infarction result in left ventricular dilatation? Heart Rhythm 2007 0.82
238 Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders. J Am Coll Cardiol 2011 0.82
239 Effect of atrioventricular and ventriculoventricular delay optimization on clinical and echocardiographic outcomes of patients treated with cardiac resynchronization therapy: a meta-analysis. Am Heart J 2013 0.82
240 Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry). Am J Cardiol 2012 0.82
241 The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy. Am Heart J 2010 0.82
242 Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study. Thromb Haemost 2014 0.82
243 Differences in atherosclerotic plaque burden and morphology between type 1 and 2 diabetes as assessed by multislice computed tomography. Diabetes Care 2009 0.82
244 Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction. Eur J Nucl Med Mol Imaging 2002 0.82
245 Quantitative analysis of the impact of total ischemic time on myocardial perfusion and clinical outcome in patients with ST-elevation myocardial infarction. Am J Cardiol 2011 0.82
246 Contribution of nursing to risk factor management as perceived by patients with established coronary heart disease. Eur J Cardiovasc Nurs 2002 0.81
247 A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals. J Hypertens 2011 0.81
248 First direct in vivo comparison of two commercially available three-dimensional quantitative coronary angiography systems. Catheter Cardiovasc Interv 2008 0.81
249 Primary PCI during off-hours is not related to increased mortality. Eur Heart J Acute Cardiovasc Care 2012 0.81
250 Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Coron Artery Dis 2009 0.81
251 Current management of hyperglycemia in acute coronary syndromes: a national Dutch survey. Crit Pathw Cardiol 2009 0.81
252 The additive prognostic value of perfusion and functional data assessed by quantitative gated SPECT in women. J Nucl Cardiol 2009 0.81
253 Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2005 0.81
254 Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery. Coron Artery Dis 2007 0.81
255 Influence of smoking on the prognostic value of cardiovascular computed tomography coronary angiography. Eur Heart J 2010 0.81
256 Computed tomography coronary angiography accuracy in women and men at low to intermediate risk of coronary artery disease. Eur Radiol 2012 0.81
257 The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n = 6129). EuroIntervention 2009 0.80
258 Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction. Int J Cardiol 2013 0.80
259 Equally valid models gave divergent predictions for mortality in acute myocardial infarction patients in a comparison of logistic [corrected] regression models. J Clin Epidemiol 2005 0.80
260 Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease. Catheter Cardiovasc Interv 2010 0.80
261 Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic model. Am J Cardiol 2003 0.80
262 Retracted Baseline plasma N-terminal pro-B-type natriuretic peptide is associated with the extent of stress-induced myocardial ischemia during dobutamine stress echocardiography. Coron Artery Dis 2006 0.80
263 Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial). Am J Cardiol 2008 0.80
264 Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioning. Basic Res Cardiol 2014 0.80
265 Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study. J Cardiovasc Electrophysiol 2005 0.80
266 The duration of the use of imatinib mesylate is only weakly related to elevated BNP levels in chronic myeloid leukaemia patients. Hematol Oncol 2010 0.80
267 Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study. EuroIntervention 2011 0.80
268 Remote ischemic conditioning in percutaneous coronary intervention and coronary artery bypass grafting. Circ J 2012 0.80
269 Prognostic value of gated SPECT in patients with left bundle branch block. J Nucl Cardiol 2007 0.79
270 Long-term outcome after statin treatment in routine clinical practice: results from a prospective PCI cohort study. EuroIntervention 2012 0.79
271 Assessment of myocardial viability by nuclear imaging techniques. Curr Cardiol Rep 2005 0.79
272 Intensity of statin therapy in relation to myocardial ischemia, troponin T release, and clinical cardiac outcome in patients undergoing major vascular surgery. J Am Coll Cardiol 2007 0.79
273 Trial participation as a determinant of clinical outcome: differences between trial-participants and Every Day Clinical Care patients in the field of interventional cardiology. Int J Cardiol 2013 0.79
274 Comparing the value of BNP in predicting mortality among community-dwelling elderly with and without overweight/obesity: the Bambuí (Brazil) Cohort Study of Aging. Int J Cardiol 2013 0.79
275 Mitral valve morphology assessment: three-dimensional transesophageal echocardiography versus computed tomography. Ann Thorac Surg 2010 0.79
276 Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation. Am Heart J 2009 0.79
277 Time course of global left ventricular strain after acute myocardial infarction. Eur Heart J 2010 0.79
278 Glycemic control, lipid-lowering treatment, and prognosis in diabetic patients with peripheral atherosclerotic disease. Ann Vasc Surg 2007 0.79
279 Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction. Cardiology 2012 0.79
280 [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. Rev Port Cardiol 2008 0.79
281 Comparison of the value of coronary calcium detection to computed tomographic angiography and exercise testing in patients with chest pain. Am J Cardiol 2009 0.79
282 Comparison of effectiveness of cardiac resynchronization therapy in patients with versus without diabetes mellitus. Am J Cardiol 2005 0.79
283 Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients. Transplantation 2015 0.79
284 Prediction of 30-day mortality in older patients with a first acute myocardial infarction. Cardiology 2009 0.79
285 Validation of two risk models for perioperative mortality in patients undergoing elective abdominal aortic aneurysm surgery. Vasc Endovascular Surg 2003 0.78
286 Sensitivity and specificity of QCA in detecting coronary arterial remodeling after intracoronary brachytherapy: a comparison to serial volumetric three-dimensional intravascular ultrasound analysis. Can we detect positive remodeling by luminography? J Invasive Cardiol 2003 0.78
287 Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy. J Am Coll Cardiol 2002 0.78
288 A response to a misrepresentation of the STEMI guidelines: the response. Heart 2013 0.78
289 Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization. J Thorac Cardiovasc Surg 2006 0.78
290 Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromes. Atherosclerosis 2012 0.78
291 Incidence of recovery of contractile function following revascularization in patients with ischemic left ventricular dysfunction. Am J Cardiol 2004 0.78
292 Effect of atorvastatin on myocardial contractile reserve assessed by tissue Doppler imaging in moderately hypercholesterolemic patients without heart disease. Am J Cardiol 2003 0.78
293 Preoperative comparison of different noninvasive strategies for predicting improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol 2003 0.78
294 Distance of lipid core-rich plaques from the ostium by NIRS in nonculprit coronary arteries. JACC Cardiovasc Imaging 2012 0.78
295 How to identify the asymptomatic high-risk patient? Curr Probl Cardiol 2009 0.78
296 Life-years gained by smoking cessation after percutaneous coronary intervention. Am J Cardiol 2013 0.78
297 Age- and gender-specific differences in the prognostic value of CT coronary angiography. Heart 2011 0.78
298 Indication for percutaneous coronary intervention is not associated with symptoms of anxiety and depression. Int J Cardiol 2013 0.78
299 Combining magnetic resonance viability variables better predicts improvement of myocardial function prior to percutaneous coronary intervention. Int J Cardiol 2011 0.78
300 Comparison of functional recovery of mildly hypokinetic versus severely dysfunctional left ventricular segments after revascularization in patients with ischemic cardiomyopathy. Am J Cardiol 2004 0.78
301 Usefulness of preoperative oral glucose tolerance testing for perioperative risk stratification in patients scheduled for elective vascular surgery. Am J Cardiol 2007 0.78
302 Tools and techniques--statistics: how many variables are allowed in the logistic and Cox regression models? EuroIntervention 2014 0.78
303 High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention. EuroIntervention 2016 0.78
304 The use of imatinib mesylate has no adverse effects on the heart function. Results of a pilot study in patients with chronic myeloid leukemia. Leuk Res 2010 0.78
305 Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial. Pulm Pharmacol Ther 2008 0.78
306 Actual management of patients with asymptomatic aortic valve disease: how practice fits with guidelines. Am Heart J 2007 0.78
307 Restriction of the referral of patients with stable angina for CT coronary angiography by clinical evaluation and calcium score: impact on clinical decision making. Eur Radiol 2013 0.78
308 Value of pulse-wave tissue Doppler imaging to identify dyssynergic but viable myocardium. Am J Cardiol 2003 0.77
309 Tools and techniques - statistics: analysis of continuous data using the t-test and ANOVA. EuroIntervention 2013 0.77
310 Assessment of right ventricular infarction with contrast-enhanced magnetic resonance imaging. Coron Artery Dis 2007 0.77
311 Association between obesity and postoperative atrial fibrillation in patients undergoing cardiac operations: a systematic review and meta-analysis. Ann Thorac Surg 2013 0.77
312 Plaque compositional Syntax score: combining angiography and lipid burden in coronary artery disease. JACC Cardiovasc Imaging 2012 0.77
313 Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years. J Thorac Cardiovasc Surg 2009 0.77
314 Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 2006 0.77
315 The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients. Anesth Analg 2009 0.77
316 Influence of cardiac risk factors and medication on length of hospitalization in patients undergoing major vascular surgery. Am J Cardiol 2006 0.77
317 Relation of genetic profile and novel circulating biomarkers with coronary plaque phenotype as determined by intravascular ultrasound: rationale and design of the ATHEROREMO-IVUS study. EuroIntervention 2014 0.77
318 Comparison between contrast echocardiography and magnetic resonance imaging to predict improvement of myocardial function after primary coronary intervention. Am J Cardiol 2005 0.77
319 Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinaemic-euglycaemic clamping. Eur J Nucl Med Mol Imaging 2002 0.76
320 Is there a difference in the diagnostic accuracy of computed tomography coronary angiography between women and men? Coron Artery Dis 2011 0.76
321 A pooled safety analysis of data comparing paclitaxel-eluting stents with bare-metal stents. EuroIntervention 2007 0.76
322 Comparison of long-term outcomes in STEMI and NSTE-ACS after coronary stent placement: an analysis in a real world BMS and DES population. Int J Cardiol 2012 0.76
323 Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease management. Expert Rev Cardiovasc Ther 2008 0.76
324 Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease. Diabetes Care 2006 0.76
325 Circulating chemokines in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and cardiovascular outcome. Biomarkers 2014 0.76
326 A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery. Coron Artery Dis 2006 0.76
327 Fibrinogen in relation to degree and composition of coronary plaque on intravascular ultrasound in patients undergoing coronary angiography. Coron Artery Dis 2017 0.76
328 Safety and feasibility of cardiac FDG SPECT following oral administration of Acipimox, a nicotinic acid derivative: Comparison of image quality with hyperinsulinemic euglycemic clamping in nondiabetic patients. J Nucl Cardiol 2002 0.75
329 Association of global weather changes with acute coronary syndromes: gaining insights from clinical trials data. Int J Biometeorol 2012 0.75
330 News update on withdrawal of Kyoto Heart Study research paper. Eur Heart J 2013 0.75
331 EuroIntervention - Methodology and Statistics Review Board. EuroIntervention 2013 0.75
332 Small abdominal aortic aneurysms. N Engl J Med 2002 0.75
333 Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary Syndromes. Am J Ther 2015 0.75
334 Cost-effectiveness of upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes. J Am Coll Cardiol 2006 0.75
335 Reply: To PMID 23021324. J Am Coll Cardiol 2013 0.75
336 Reply: amino terminal fragment of pro-B-type natriuretic peptide for complex congenital heart diseases: one for all, all for one? J Am Coll Cardiol 2014 0.75
337 Beta-blocker therapy in noncardiac surgery. N Engl J Med 2005 0.75
338 Percutaneous coronary intervention related delay in ST-segment elevation myocardial infarction patients. J Am Coll Cardiol 2009 0.75
339 Direct thrombin inhibitors in acute coronary syndrome patients undergoing percutaneous coronary intervention: special effects in selected patients? Eur Heart J 2005 0.75
340 Does resting two-dimensional echocardiography identify patients with ischemic cardiomyopathy and low likelihood of functional recovery after coronary revascularization? Coron Artery Dis 2004 0.75
341 Tools & techniques methodology and statistics: randomisation in clinical trials. EuroIntervention 2013 0.75
342 The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis - Intravascular Ultrasound (ATHEROREMO-IVUS) Study. EuroIntervention 2017 0.75
343 Optimized stent implantation according to intracoronary Doppler-derived parameters. Am J Cardiol 2002 0.75
344 Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH). EuroIntervention 2014 0.75
345 Tools and techniques--Statistics: descriptive statistics. EuroIntervention 2013 0.75
346 Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries. EuroIntervention 2016 0.75
347 No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial. Am Heart J 2007 0.75
348 Benefits of coronary revascularisation in diabetic and non-diabetic patients with ischaemic cardiomyopathy: role of myocardial viability. Eur J Heart Fail 2005 0.75
349 Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy). Cardiology 2002 0.75
350 Comparison of long-term effect of coronary artery bypass grafting in patients with ischemic cardiomyopathy with viable versus nonviable left ventricular myocardium. Am J Cardiol 2004 0.75
351 Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy. Curr Opin Cardiol 2008 0.75
352 Magnetic navigation system assisted stenting of coronary bifurcation lesions. EuroIntervention 2011 0.75
353 Development and internal validation of a practical model to identify observe patients of the European Society of Cardiology 0/1-hour algorithm at low risk of a coronary diagnosis. Cardiology 2022 0.75
354 Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration. J Nucl Med 2003 0.75
355 The impact of age on effects of pre-hospital initiation of high bolus dose of tirofiban before primary angioplasty for ST-elevation myocardial infarction. Cardiovasc Drugs Ther 2011 0.75
356 Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months. EuroIntervention 2017 0.75
357 Sex differences in plaque characteristics by intravascular imaging in patients with coronary artery disease. EuroIntervention 2016 0.75
358 Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial). Am J Cardiol 2009 0.75
359 Noninvasive Prediction of Atherosclerotic Progression: The PROSPECT-MSCT Study. JACC Cardiovasc Imaging 2015 0.75
360 Lipid core burden index and Framingham score: can a Systemic Risk Score predict lipid core burden in non-culprit coronary artery? Int J Cardiol 2012 0.75
361 Effect of chronic beta-blocker use on stroke after noncardiac surgery. Am J Cardiol 2009 0.75
362 Coronary revascularization for non-ST elevation acute coronary syndrome: state of the art. J Cardiovasc Med (Hagerstown) 2006 0.75
363 The IGF-I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial. Clin Endocrinol (Oxf) 2006 0.75
364 Optimizing long-term cardiac management after major vascular surgery: Role of beta-blocker therapy, clinical characteristics, and dobutamine stress echocardiography to optimize long-term cardiac management after major vascular surgery. Arch Intern Med 2003 0.75
365 Microsimulation for clinical decision-making in individual patients with established coronary artery disease: a concept. Circ J 2012 0.75
366 First-Line Support by Intra-Aortic Balloon Pump in Non-Ischaemic Cardiogenic Shock in the Era of Modern Ventricular Assist Devices. Cardiology 2017 0.75
367 A clinical and echocardiographic score for assigning risk of major events after dobutamine echocardiograms. J Am Coll Cardiol 2004 0.75
368 Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial. Can J Cardiol 2004 0.75
369 Assessment of viable tissue in Q-wave regions by metabolic imaging using single-photon emission computed tomography in ischemic cardiomyopathy. Am J Cardiol 2002 0.75
370 Tools and techniques - statistical: it's statistically significant, but is it clinically relevant? EuroIntervention 2015 0.75
371 Prehospital thrombolysis with reteplase: the Nijmegen/Rotterdam study. Am Heart J 2003 0.75
372 Prognostic value of perfusion-FDG mismatch in ischemic cardiomyopathy. J Nucl Cardiol 2002 0.75
373 Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe. EuroIntervention 2011 0.75
374 Tools and Techniques - Statistical: A brief non-statistician's guide for choosing the appropriate regression analysis, with special attention to correlated data and repeated measurements. EuroIntervention 2015 0.75
375 Site-specific intracoronary delivery of octreotide in humans: a pharmacokinetic study to determine dose-efficacy in restenosis prevention. J Cardiovasc Pharmacol 2004 0.75
376 Risk-benefit analysis of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Expert Opin Drug Saf 2003 0.75
377 Drug-eluting stent implantation in acute myocardial infarction. Do we need another randomised trial? (TYPHOON, PASSION and HORIZONS trials). EuroIntervention 2006 0.75
378 Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty. J Am Coll Cardiol 2002 0.75
379 Percutaneous coronary interventions for acute myocardial infarction. EuroIntervention 2011 0.75